Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $472.43 ($4.6M) on 2026-09-28, disclosed to the SEC on 2026-09-29.
Scheduled sale ($4.6M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $472.43 | 280 | $132K | 2.9% |
| 2 | $473.28 | 600 | $284K | 6.2% |
| 3 | $474.46 | 680 | $323K | 7.1% |
| 4 | $475.28 | 80 | $38K | 0.8% |
| 5 | $476.68 | 160 | $76K | 1.7% |
| 6 | $477.45 | 200 |
| $95K |
| 2.1% |
| 7 | $479.06 | 601 | $288K | 6.3% |
| 8 | $480.18 | 1,013 | $486K | 10.6% |
| 9 | $481.20 | 1,354 | $652K | 14.3% |
| 10 | $482.11 | 693 | $334K | 7.3% |
| 11 | $483.20 | 1,539 | $744K | 16.3% |
| 12 | $484.47 | 825 | $400K | 8.7% |
| 13 | $485.45 | 1,315 | $638K | 14.0% |
| 14 | $486.00 | 160 | $78K | 1.7% |
| Total | $480.85 avg | 9,500 | $4.6M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-09 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-08 | $5.2M | — | Filing → |